Staff at Thunder Bay’s overdose prevention site are warning people about possible tainted drugs in the city, according to the director of health services for its operator, Norwest Community Health Centres.
Author of the article: Postmedia Staff
Publishing date: May 20, 2021 • 32 minutes ago • 2 minute read • Ontario health units are warning of increased opioid poisonings and of drugs laced with potentially lethal opioids unsafe for human consumption. They offer free naloxone kits to counteract - temporarily - the effects of overdose. Photo by Emma Meldrum /Emma Meldrum/The Daily Press
Article content
On the heels of a troubling new report about increasing opioid deaths locally and across Ontario, health units are warning of tainted drugs now in circulation.
Hastings and Prince Edward Counties have not recorded a spike in opioid toxicity in recent weeks, the release noted, but neighbouring regions from Peterborough to Leeds-Grenville have – and such cases are not always reported, Hastings Prince Edward Public Health announced Thursday in a news release.
Health units issuing alerts as overdoses rise, tainted drugs found thewhig.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thewhig.com Daily Mail and Mail on Sunday newspapers.
Published Friday, May 7, 2021 4:18PM EDT Toronto Public Health has issued a drug alert after a new single-day record was set with five suspected opioid overdose deaths. Between May 2 and May 6, TPH said Toronto Paramedic Services responded to 13 fatal suspected opioid-related overdose calls, including the five fatalities on Wednesday. The health unit noted it is the “worst cluster” of suspected overdose deaths since they began collecting data in 2017. “These fatal calls have occurred across Toronto,” TPH said. “The tragic loss of 13 lives highlights the unpredictable nature of the unregulated drug supply.” TPH said supervised injection sites are also reporting an increase in overdoses. At the same time, they are noticing a growing number of “unexpected substances of concern” in the drug supply.